Multiple Manufacturers

ORPHENADRINE CITRATE

Manufacturer:

Multiple Manufacturers

Orphenadrine Citrate HCPCS:

J2360

HCPCS Code Descriptor:

Injection, orphenadrine citrate, up to 60 mg

Category:

J Code

Orphenadrine Citrate NDCs:

17478-0538-02, 00641-6182-10, 25021-0651-02

Primary Type:

Muscle Relaxant

Generic/Specialty Status:

Multi-Source

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

17478-0538-02, 25021-0651-02

About Orphenadrine Citrate:

ORPHENADRINE CITRATE is a Muscle Relaxant drug manufactured by Akorn and administered via the Injection route of administration. The J Code: J2360 is aligned to the drug ORPHENADRINE CITRATE.

ACCESS PRICING AND MORE BY REGISTERING

J2360 Added Date:

January 1, 1982

J2360 Effective Date:

January 1, 1997

J2360 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Orphenadrine Citrate billing and coding information.
Our team did not identify a source for Orphenadrine Citrate patient assistance information. Please reach out to our team if you feel that this is a mistake.
Our team is still working to identify a prescribing information source for ORPHENADRINE CITRATE
Our team has not yet identified a source of side effects information for ORPHENADRINE CITRATE. Please check back in a few weeks.